Comparison of seven immunoassays for the quantification of CA 125 antigen in serum [PDF]
Clinical Chemistry, 1998 Abstract Seven CA 125 immunoassays were compared for their clinical performance. CA 125 concentrations were determined in 289 serum samples obtained from women with benign pelvic tumors (samples from 98 patients) and patients with various cancers (samples from 111 patients).
E M, Davelaar +3 more
openaire +2 more sources
Tumor Markers in Patients with Chronic Renal Failure
The International Journal of Biological Markers, 1990 In order to evaluate the specificity of tumor markers in chronic renal failure, we have determined serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19.9 (CA 19.9), carbohydrate antigen 50 (CA 50), alfafetoprotein (AFP), neuron ...
X. Filella +6 more
doaj +1 more source
Evaluation of Probably Benign Adnexal Masses in Postmenopausal Women [PDF]
Revista Brasileira de Ginecologia e Obstetrícia, 2017 Background Preoperatively identification of malignancy potential of a postmenopausal adnexal masses is important. Aim To evaluate the effectiveness of the Risk of Malignancy Index-2 in presumably benign adnexal masses in postmenopausal women.
Burcu Kisa Karakaya +6 more
doaj +2 more sources
Comparison of Serum CA-125 Level in Ruptured and Unruptured Tubal Pregnancies in Yazd/Iran during 2001-2006 [PDF]
Journal of Kerman University of Medical Sciences, 2009 Background & Aims: This study aimed to determine if serial measurement of serum CA-125 level could be used as a useful test in the differential diagnosis of intact and ruptured tubal pregnancies. Methods: In a single-blind prospective controlled clinical
L Sekhavat, M Mojibian, M Karimi zarchi
doaj
Clinical Evaluation of a New Two-Site Assay for CA125 Antigen
The International Journal of Biological Markers, 1991 As appropriate surgery and chemotherapy can improve both quality of life and survival of patients with ovarian adenocarcinoma, there has been a pressing need for “serodiagnostic” assays to enable close patient monitoring.
V. Capstick +7 more
doaj +1 more source
The role of asymptomatic screening in the detection of recurrent ovarian cancer
Gynecologic Oncology Reports, 2020 Objective: To investigate the utility of asymptomatic screening, including CA-125, imaging, and pelvic exam, in the diagnosis and management of recurrent ovarian cancer.
M.T. Richardson +6 more
doaj +1 more source
Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: Pretreatment levels or kinetics during chemotherapy? [PDF]
, 2007 Background: The carbohydrate antigen 19-9 (CA 19-9) is currently the most widely used serum tumor marker in pancreatic cancer (PC). CA 19-9 pretreatment levels as well as CA 19-9 kinetics during systemic chemotherapy can provide prognostic information ...
Holdenrieder, Stefan +5 more
core +1 more source
Predictive Factors of Non-Elevation of Carcinoembryonic Antigen 125 in Acute Heart Failure
LifeThis study aims to analyze the factors associated with the lack of carbohydrate antigen 125 (CA-125) elevation in cases of acute heart failure (HF) decompensation.
Raquel López-Vilella +8 more
doaj +1 more source
CA 125 Elevation: A Descriptive Etiological Study [PDF]
National Journal of Laboratory Medicine, 2016 Introduction: CA 125 (Cancer/Carbohydrate antigen 125) is a surface antigen expressed mostly by the ovarian cancer cells. Hence, it is widely used as a tumour marker for detection and monitoring the progression of such cancers.
Shaheena Appan Parambath +6 more
doaj +1 more source
Comparison of Adenosine Deaminase (ADA) and Cancer Antigen 125 (CA 125) Levels in Epithelial Ovarian Tumors [PDF]
, 2019 Introduction: In this study, we aimed to determine serum adenosine deaminase (ADA) and cancer antigen 125 (CA 125)levels in patients with epithelial ovarian tumors.Methods: A total of 75 patients with 47 malignant and 28 benign epithelial ovarian tumors ...
Korun, Zeynep Ece Utkan +6 more
core +1 more source